Department of Molecular and Cellular Biology, Harvard University, Cambridge, United States
Steven Zimmerman
Department of Molecular and Cellular Biology, Harvard University, Cambridge, United States
Deniz C Aksel
Program in Biophysics, Harvard Medical School, Boston, United States
Deepak Reyon
Molecular Pathology Unit, Massachusetts General Hospital, Charlestown, United States; Department of Pathology, Harvard Medical School, Boston, United States; Center for Computational and Integrative Biology, Massachusetts General Hospital, Boston, United States; Center for Cancer Research, Massachusetts General Hospital, Charlestown, United States
Shengdar Q Tsai
Molecular Pathology Unit, Massachusetts General Hospital, Charlestown, United States; Department of Pathology, Harvard Medical School, Boston, United States; Center for Computational and Integrative Biology, Massachusetts General Hospital, Boston, United States; Center for Cancer Research, Massachusetts General Hospital, Charlestown, United States
J Keith Joung
Molecular Pathology Unit, Massachusetts General Hospital, Charlestown, United States; Department of Pathology, Harvard Medical School, Boston, United States; Center for Computational and Integrative Biology, Massachusetts General Hospital, Boston, United States; Center for Cancer Research, Massachusetts General Hospital, Charlestown, United States
Department of Molecular and Cellular Biology, Harvard University, Cambridge, United States; Broad Institute of MIT and Harvard University, Cambridge, United States; Center for Brain Science, Harvard University, Cambridge, United States; Harvard Stem Cell Institute, Harvard University, Cambridge, United States; Center for Systems Biology, Harvard University, Cambridge, United States
Developmental signaling pathways often activate their own inhibitors. Such inhibitory feedback has been suggested to restrict the spatial and temporal extent of signaling or mitigate signaling fluctuations, but these models are difficult to rigorously test. Here, we determine whether the ability of the mesendoderm inducer Nodal to activate its inhibitor Lefty is required for development. We find that zebrafish lefty mutants exhibit excess Nodal signaling and increased specification of mesendoderm, resulting in embryonic lethality. Strikingly, development can be fully restored without feedback: Lethal patterning defects in lefty mutants can be rescued by ectopic expression of lefty far from its normal expression domain or by spatially and temporally uniform exposure to a Nodal inhibitor drug. While drug-treated mutants are less tolerant of mild perturbations to Nodal signaling levels than wild type embryos, they can develop into healthy adults. These results indicate that patterning without inhibitory feedback is functional but fragile.